Bank of Montreal’s Legend Biotech LEGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-12,025
Closed -$261K 3908
2025
Q4
$261K Buy
12,025
+2,696
+29% +$77.2K ﹤0.01% 2682
2025
Q3
$304K Buy
+9,329
New +$344K ﹤0.01% 2515
2021
Q2
Sell
-410
Closed -$12K 4363
2021
Q1
$12K Buy
+410
New +$11.2K ﹤0.01% 4278

Other funds holding LEGN

Bank of Montreal's LEGN Position: Q1 2026 in Review

Bank of Montreal sold out of Legend Biotech (LEGN) in Q1 2026, closing a stake of 12,025 shares — an estimated $261K sold.

Bank of Montreal first reported a position in LEGN in Q1 2021 and held it in 3 quarters. The position peaked at $304K in Q3 2025. 191 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.

  • Bank of Montreal reported no remaining Legend Biotech position as of Q1 2026 after selling out during the quarter.
  • Bank of Montreal sold 12,025 Legend Biotech shares in Q1 2026, an estimated $261K.
  • Bank of Montreal first reported a position in Legend Biotech in Q1 2021 and held it in 3 quarters.
  • Bank of Montreal's Legend Biotech position peaked at $304K in Q3 2025.
  • 191 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.

Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.